Sue Gilroy

Connect with us

National

Influenza drug enisamium a potential COVID-19 treatment – News-Medical.Net

Researchers in Europe and the United States have demonstrated the potential of the influenza drug enisamium as a treatment for infection with severe acute respiratory…

Published

on

post featured image

Researchers in Europe and the United States have demonstrated the potential of the influenza drug enisamium as a treatment for infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
Aartjan te Velthuis from the University of Cambridge in the UK and colleagues showed that enisamium prevented SARS-CoV-2 replication in human cell lines and stopped viral RNA synthesis in vitro.
Furthermore, in a double-blind, randomized,…

Click here to view the original article.

Sue Gilroy